Literature DB >> 14715543

Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.

S Q Wales1, C C Smith, M Wachsman, G Calton, L Aurelian.   

Abstract

In response to the increasingly evident need for herpes simplex virus (HSV) serotype-specific serologic assays that rely on proteins other than glycoprotein-G (gG), we developed a rapid serologic assay that is based on type-specific epitopes within the large subunit of HSV ribonucleotide reductase (R1). The assay (Au-2 enzyme-linked immunosorbent assay [ELISA]) uses an HSV type 2 (HSV-2) R1 peptide antigen. It provides a reliable method for detecting serotype-specific antibody to a protein other than gG-2. The Au-2 ELISA has high sensitivity and specificity as determined by direct comparison to Western blotting, a widely accepted "gold standard," and to ELISA with an HSV-1 R1 peptide (Au-1). The use of the Au-2 ELISA in conjunction with the gG-2-based assays will improve the sensitivity and specificity of serologic diagnosis and patient management.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715543      PMCID: PMC321330          DOI: 10.1128/cdli.11.1.42-49.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  62 in total

1.  Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies.

Authors:  H E Prince; C E Ernst; W R Hogrefe
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Detection of herpes simplex virus type-specific antibodies by an enzyme-linked immunosorbent assay based on glycoprotein G.

Authors:  M Hashido; F K Lee; S Inouye; T Kawana
Journal:  J Med Virol       Date:  1997-12       Impact factor: 2.327

3.  Variability of the glycoprotein G gene in clinical isolates of herpes simplex virus type 1.

Authors:  E Rekabdar; P Tunbäck; J A Liljeqvist; T Bergström
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  HSV-1 and HSV-2 in herpes simplex encephalitis: a study of sixty-four cases in the United Kingdom.

Authors:  C Dennett; G M Cleator; P E Klapper
Journal:  J Med Virol       Date:  1997-09       Impact factor: 2.327

5.  Herpes simplex virus type 2 glycoprotein G-negative clinical isolates are generated by single frameshift mutations.

Authors:  J A Liljeqvist; B Svennerholm; T Bergström
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes.

Authors:  P Wutzler; H W Doerr; I Färber; U Eichhorn; B Helbig; A Sauerbrei; A Brandstädt; H F Rabenau
Journal:  J Med Virol       Date:  2000-06       Impact factor: 2.327

7.  Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.

Authors:  A Wald; L Corey; R Cone; A Hobson; G Davis; J Zeh
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

8.  Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents.

Authors:  Charles T Leach; Rhoda L Ashley; Jacques Baillargeon; Hal B Jenson
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections.

Authors:  D W Ho; P R Field; W L Irving; D R Packham; A L Cunningham
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

10.  The novel protein kinase of the RR1 subunit of herpes simplex virus has autophosphorylation and transphosphorylation activity that differs in its ATP requirements for HSV-1 and HSV-2.

Authors:  T Peng; J R Hunter; J W Nelson
Journal:  Virology       Date:  1996-02-01       Impact factor: 3.616

View more
  3 in total

1.  Performance of two commercial enzyme-linked immunosorbent assay kits using recombinant glycoprotein G2 antigen for detection of herpes simplex virus type 2 specific antibodies.

Authors:  Sharmila M Reddy; P Balakrishnan; S Uma; S P Thyagarajan; Suniti Solomon
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

2.  Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55.

Authors:  A M Al-Sulaiman; P J Vallely; P E Klapper
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

3.  Tobacco mosaic virus in the lungs of mice following intra-tracheal inoculation.

Authors:  Fanny Balique; Philippe Colson; Abdoulaye Oury Barry; Claude Nappez; Audrey Ferretti; Khatoun Al Moussawi; Tatsiana Ngounga; Hubert Lepidi; Eric Ghigo; Jean-Louis Mege; Hervé Lecoq; Didier Raoult
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.